futibatinib
otsuka
['futibatinib', 'taiho']
#taihooncology announces updated efficacy and safety data for #futibatinib in #cholangiocarcinoma at #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.